Infinium Pharmachem Limited — Others, 04-03-2025: Statement of deviation(s) or variation(s) under Reg. 32

Infinium Pharmachem Limited has announced a board meeting to present the financial results for the quarter and half-year. Notably, there is no deviation in the utilization of funds raised through its Initial Public Offer (IPO), which amounted to ₹25.31 crore, covering the issue of 1,875,000 equity shares. This assurance of proper fund usage may strengthen investor confidence and reflects effective financial governance within the company. The consistent management of IPO funds is likely to lead to a positive outlook among investors, minimizing potential risks associated with fund misallocation.